Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8950381rdf:typepubmed:Citationlld:pubmed
pubmed-article:8950381lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:8950381lifeskim:mentionsumls-concept:C0685938lld:lifeskim
pubmed-article:8950381lifeskim:mentionsumls-concept:C0694634lld:lifeskim
pubmed-article:8950381lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:8950381lifeskim:mentionsumls-concept:C1517927lld:lifeskim
pubmed-article:8950381lifeskim:mentionsumls-concept:C0031928lld:lifeskim
pubmed-article:8950381lifeskim:mentionsumls-concept:C0019014lld:lifeskim
pubmed-article:8950381lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:8950381lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:8950381pubmed:issue5lld:pubmed
pubmed-article:8950381pubmed:dateCreated1997-1-9lld:pubmed
pubmed-article:8950381pubmed:abstractTextIntra-arterial chemotherapy combined with haemofiltration enables the administration of drugs to confined neoplastic tissue while limiting the systemic drug exposure. During the procedure, the cytotoxic drugs are injected into the arterial supply of the tumour and the venous blood coming from the tumour bed is pumped out and filtered trough haemofiltration unit in order to extract the cytotoxic drug not fixed on the tumour. The patients selected for such treatment failed previous intravenous chemotherapy. Thirteen patients underwent intra-arterial chemotherapy injections combined with haemofiltration procedures: 8 unresectable liver metastases from colorectal cancer and 5 pelvic recurrences from rectal cancer. Fluorouracil, mitomycin C and doxorubicin were infused. One out of thirteen patients presented a complete regression of his liver metastases, 5/13 presented a partial regression, 2/13 patients did not show any significant modification of the size of their lesions and were classified as stable disease, 5/13 patients showed a progression of their neoplastic disease. No nephrotoxicity or major gastrointestinal side effects were observed. Intra-arterial chemotherapy combined with haemofiltration procedure is a therapeutic modality that could be considered in patients with locally advanced cancer who failed previous first line intravenous chemotherapy.lld:pubmed
pubmed-article:8950381pubmed:languageenglld:pubmed
pubmed-article:8950381pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8950381pubmed:citationSubsetIMlld:pubmed
pubmed-article:8950381pubmed:statusMEDLINElld:pubmed
pubmed-article:8950381pubmed:issn0001-5458lld:pubmed
pubmed-article:8950381pubmed:authorpubmed-author:VanherweghemJ...lld:pubmed
pubmed-article:8950381pubmed:authorpubmed-author:LambilliotteJ...lld:pubmed
pubmed-article:8950381pubmed:authorpubmed-author:PanditNNlld:pubmed
pubmed-article:8950381pubmed:authorpubmed-author:GhanemGGlld:pubmed
pubmed-article:8950381pubmed:authorpubmed-author:BertinLLlld:pubmed
pubmed-article:8950381pubmed:authorpubmed-author:TatonGGlld:pubmed
pubmed-article:8950381pubmed:authorpubmed-author:SalariAAlld:pubmed
pubmed-article:8950381pubmed:authorpubmed-author:ThaysseCClld:pubmed
pubmed-article:8950381pubmed:authorpubmed-author:IckxBBlld:pubmed
pubmed-article:8950381pubmed:authorpubmed-author:GoldzarianJJlld:pubmed
pubmed-article:8950381pubmed:authorpubmed-author:MedhiAAlld:pubmed
pubmed-article:8950381pubmed:issnTypePrintlld:pubmed
pubmed-article:8950381pubmed:volume96lld:pubmed
pubmed-article:8950381pubmed:ownerNLMlld:pubmed
pubmed-article:8950381pubmed:authorsCompleteYlld:pubmed
pubmed-article:8950381pubmed:pagination206-10lld:pubmed
pubmed-article:8950381pubmed:dateRevised2006-4-24lld:pubmed
pubmed-article:8950381pubmed:meshHeadingpubmed-meshheading:8950381-...lld:pubmed
pubmed-article:8950381pubmed:meshHeadingpubmed-meshheading:8950381-...lld:pubmed
pubmed-article:8950381pubmed:meshHeadingpubmed-meshheading:8950381-...lld:pubmed
pubmed-article:8950381pubmed:meshHeadingpubmed-meshheading:8950381-...lld:pubmed
pubmed-article:8950381pubmed:meshHeadingpubmed-meshheading:8950381-...lld:pubmed
pubmed-article:8950381pubmed:meshHeadingpubmed-meshheading:8950381-...lld:pubmed
pubmed-article:8950381pubmed:meshHeadingpubmed-meshheading:8950381-...lld:pubmed
pubmed-article:8950381pubmed:meshHeadingpubmed-meshheading:8950381-...lld:pubmed
pubmed-article:8950381pubmed:meshHeadingpubmed-meshheading:8950381-...lld:pubmed
pubmed-article:8950381pubmed:meshHeadingpubmed-meshheading:8950381-...lld:pubmed
pubmed-article:8950381pubmed:meshHeadingpubmed-meshheading:8950381-...lld:pubmed
pubmed-article:8950381pubmed:meshHeadingpubmed-meshheading:8950381-...lld:pubmed
pubmed-article:8950381pubmed:meshHeadingpubmed-meshheading:8950381-...lld:pubmed
pubmed-article:8950381pubmed:meshHeadingpubmed-meshheading:8950381-...lld:pubmed
pubmed-article:8950381pubmed:meshHeadingpubmed-meshheading:8950381-...lld:pubmed
pubmed-article:8950381pubmed:articleTitleFirst results of a clinical pilot study on intraarterial chemotherapy with haemofiltration of locally advanced gastrointestinal cancers.lld:pubmed
pubmed-article:8950381pubmed:affiliationDepartment of Gastrointestinal Surgery Surgical Oncology, Hôpital Erasme, Brussels, Belgium.lld:pubmed
pubmed-article:8950381pubmed:publicationTypeJournal Articlelld:pubmed